Society for Phytotherapy: Schwabe's Stephan Köhler elected as the new Chair
2025-11-20
At yesterday’s meeting of the Advisory Board of Corporate Members of the Society for Phytotherapy at Pharma Deutschland in Bonn, the board held its scheduled session and addressed key topics for the future of phytotherapy.
A central point of the meeting was the election of the entire Advisory Board, with our colleague Stephan Köhler, Director Global Pharmacovigilance at the Schwabe Group, chosen as the new Chair. Congratulations, Stephan, on taking on this important responsibility!
We, as the Schwabe Group, are truly delighted that you have taken on this role to further drive innovation and uphold the highest quality standards in phytopharmaceuticals worldwide.
In addition to the inaugural session, the board focused on comments on European guidelines, including the Reflection Paper on Patient Experience Data—a document that will shape future regulatory expectations and strengthen patient-centric approaches across the healthcare landscape.
Caption: The Advisory Board, from left to right: Dr. Inga Trompetter, Prof. Dr. Freimut Schliess, Dr. Barbara Steinhoff, Dr. Stephan Köhler, Dr. Christoph Theurer, Prof. Dietmar Kammerer, Dr. Nico Symma.